Fulcrum Therapeutics logo
Fulcrum Therapeutics FULC
$ 3.2 7.58%

Quarterly report 2024-Q3
added 11-13-2024

report update icon

Fulcrum Therapeutics EBITDA per Share 2011-2024 | FULC

Annual EBITDA per Share Fulcrum Therapeutics

2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
-1.77 K -2.45 K -2.22 K -2.48 -3.63 - - - - - - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
-2.48 -2.45 K -1.29 K

Quarterly EBITDA per Share Fulcrum Therapeutics

2024-Q3 2024-Q2 2024-Q1 2023-Q4 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
-0.4 0.85 -474 - -0.44 -0.43 -458 - -514 -820 -626 - -551 -582 -0.52 - -682 -642 -804 - -928 -7.27 K -22.4 K - -6.5 K -6.45 K - - - - - - - - - - - - - - - - - - - - - - - - - - - - -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
0.85 -22.4 K -2.48 K